Common Contracts
11 similar null contracts by Agritech Worldwide, Inc., Biolife Solutions Inc, Diffusion Pharmaceuticals Inc., others
COMMON STOCK PURCHASE WARRANT SPECTAIRE HOLDINGS INC.Spectaire Holdings Inc. • March 21st, 2024 • Measuring & controlling devices, nec
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, True Remainders Ltd. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Issuance Date”) and on or prior to 5:00 p.m. (New York City time) on March 18, 2027 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Spectaire Holdings Inc., a Delaware corporation (the “Company”), up to 1,538,461 shares (as subject to adjustment hereunder, the “Warrant Shares”) of common stock, par value $0.0001 (“Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
PROGRESSIVE CARE INC. COMMON STOCK PURCHASE WARRANTNextPlat Corp • May 11th, 2023 • Telephone communications (no radiotelephone) • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [______] or his or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on May [__], 2026 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Progressive Care Inc., a Delaware corporation (the “Company”), up to [____] shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
PROGRESSIVE CARE INC. SERIES B PREFERRED STOCK PURCHASE WARRANTProgressive Care Inc. • September 6th, 2022 • Retail-drug stores and proprietary stores
THIS PREFERRED STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, NEXTPLAT CORP or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on September 2, 2027 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Progressive Care Inc., a Delaware corporation (the “Company”), up to 3,000 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Series B Preferred Stock (“Preferred Stock”). The purchase price of one share of Preferred Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
EX-4.1 3 d354583dex41.htm EX-4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION...New York • May 5th, 2020
THIS WARRANT MAY NOT BE EXERCISED UNTIL THE INITIAL EXERCISE DATE, WHICH IS DEFINED AS THE DATE ON WHICH THE COMPANY RECEIVES APPROVAL FROM THE REQUIRED AMOUNT OF ITS SHAREHOLDERS TO FILE, AND SUBSEQUENTLY FILES AN AMENDMENT TO ITS CERTIFICATE OF INCORPORATION INCREASING THE NUMBER OF ITS AUTHORIZED SHARES OF COMMON STOCK TO AN AMOUNT GREATER THAN 250,000,000 SHARES. THERE IS NO ASSURANCE THAT SUCH APPROVAL WILL BE RECEIVED AND, AS SUCH, THAT THIS WARRANT WILL EVER BECOME EXERCISABLE.
COMMON STOCK PURCHASE WARRANT DIFFUSION PHARMACEUTICALS INC.Diffusion Pharmaceuticals Inc. • March 15th, 2017 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five (5) year anniversary of the final closing date of the Offering (the “Termination Date”) but not thereafter, to subscribe for and purchase from Diffusion Pharmaceuticals Inc., a Delaware corporation (the “Company”), up to ______1 shares (the “Warrant Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock”).
FORM OF WARRANTAgritech Worldwide, Inc. • May 19th, 2016 • Grain mill products • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Jonathan Kahn or his assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any lime on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Z Trim Holdings, Inc., an Illinois corporation (the “Company”), up to 400,000 shares (as subject to adjustment hereunder, the “Warrant Shares”) of common stock, par value $0.0005 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 1 (b).
FORM OF WARRANTAgritech Worldwide, Inc. • May 19th, 2016 • Grain mill products • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Jonathan Kahn or his assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to the close of business on the five (5) year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Z Trim Holdings, Inc., an Illinois corporation (the “Company”), up to 500,000 shares (as subject to adjustment hereunder, the “Warrant Shares”) of common stock, par value $0.0005 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section l(b).
ContractBiolife Solutions Inc • March 25th, 2014 • Electromedical & electrotherapeutic apparatus • New York
THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “U.S. SECURITIES ACT”). THIS WARRANT MAY NOT BE EXERCISED IN THE UNITED STATES OR BY OR ON BEHALF OF A U.S. PERSON UNLESS REGISTERED UNDER THE U.S. SECURITIES ACT OR AN EXEMPTION FROM SUCH REGISTRATION IS AVAILABLE. THE TERMS “UNITED STATES” AND “U.S. PERSON” ARE AS DEFINED IN REGULATION S UNDER THE U.S. SECURITIES ACT.
AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANT Senesco Technologies, Inc.Senesco Technologies Inc • February 27th, 2014 • Services-commercial physical & biological research • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Initial Exercise Date set forth above, and on or prior to the close of business on February 21, 2014 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Senesco Technologies, Inc., a Delaware corporation (the “Company”), ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the common stock, par value $0.01 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant hereby amends and restates in its entirety the Common Stock Purchase Warrant of the Company with an exercise price of $4.00 per share and a term of six months issued to the Ho
COMMON STOCK PURCHASE WARRANT FIBROCELL SCIENCE, INC.Fibrocell Science, Inc. • May 15th, 2012 • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Initial Exercise Date (as defined herein) and on or prior to the close of business on the fifth (5th) anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Fibrocell Science, Inc., a Delaware corporation (the “Company”), up to shares (the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
COMMON STOCK PURCHASE WARRANT EPICEPT CORPORATIONEpicept Corp • May 31st, 2011 • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, MidCap Financial, LLC, a Delaware limited liability company, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issue Date and on or prior to the close of business on May 27, 2016 (the “Termination Date”) but not thereafter, to subscribe for and purchase from EpiCept Corporation, a Delaware corporation (the “Company”), up to 1,092,063 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock, par value $0.0001 per share, of the Company (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
